Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Tonix Pharmaceuticals (TNXP) Prices 2.33M Common Stock Offering at $7.50/Share
July 14, 2015 8:35 AM EDTTonix Pharmaceuticals (NASDAQ: TNXP) announced the pricing of an underwritten public offering of 2,325,000 shares of its common stock at a price of $7.50 per share. The company has also granted to the underwriters a 45-day option to acquire an additional 348,750 shares to cover overallotments... More
Tonix Pharmaceuticals (TNXP) Plans Common Stock Offering
July 13, 2015 4:03 PM EDTTonix Pharmaceuticals (NASDAQ: TNXP) announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the... More
